Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Lilly presents new factor Xa inhibitors

Nov. 14, 2003

Antithrombotic efficacy of the PAR-1 antagonist E-5555 in guinea pigs

Nov. 14, 2003

Enrollment begins in ASSENT 4 PCI trial

Nov. 13, 2003

Efficacy and safety of NO-aspirin demonstrated in mice and in healthy subjects

Nov. 13, 2003

Ajinomoto presents novel benzodiazepine-based factor Xa inhibitors

Nov. 11, 2003

A high dose of ximelagatran better than warfarin in preventing DVT after total knee replacement

Nov. 11, 2003

GH-9001 enters phase Ib trials in U.K.

Nov. 7, 2003

T-2639, a novel PAI-1 inhibitor, presented at AIMECS 03

Nov. 6, 2003

Schering AG claims novel inhibitors of carboxypeptidase B and their use in thrombotic disorders

Nov. 6, 2003

Two series of PAI-1 inhibitors designed by Schering AG researchers

Nov. 5, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...